Brain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia

European Journal of Haematology

Volumn 87, Issue 6, 2011, Pages 539-546

  Musallam, Khaled M ^a   Beydoun, Ahmad ^a   Hourani, Roula ^a   Nasreddine, Wassim ^b   Raad, Roy ^a   Koussa, Suzanne ^c   Taher, Ali T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^c Chronic Care Center Hazmieh   (Lebanon)

Author keywords

Brain; Magnetic resonance angiography; Silent stroke; Splenectomy; Thalassemia intermedia

Indexed keywords

ADULT; ANEURYSM; ARTERY OCCLUSION; ARTICLE; BETA THALASSEMIA; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; SPLENECTOMY;

ADULT; BETA-THALASSEMIA; BRAIN; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MODELS, MOLECULAR; PROSPECTIVE STUDIES; SPLENECTOMY;

EID: 81255176258     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01706.x     Document Type: Article

References (37)

1. Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood 2009;114:5117-25.
2. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99:36-43.
3. Cappellini MD, Motta I, Musallam KM, Taher AT. Redefining thalassemia as a hypercoagulable state. Ann N Y Acad Sci 2010;1202:231-6.
4. Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD. Prevalence of thromboembolic events among 8, 860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 2006;96:488-91.
5. Taher AT, Musallam KM, El-Beshlawy A, Karimi M, Daar S, Belhoul K, Saned MS, Graziadei G, Cappellini MD. Age-related complications in treatment-naive patients with thalassaemia intermedia. Br J Haematol 2010;150:486-9.
6. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010;115:1886-92.
7. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000;111:467-73.
8. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned M, Cesaretti C, Cappellini MD. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost 2010;8:2152-8.
9. Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 2010;1202:1-9.
10. Manfre L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR Am J Roentgenol 1999;173:1477-80.
11. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost 2010;8:54-9.
12. Karimi M, Bagheri H, Rastgu F, Rachmilewitz EA. Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia. Thromb Haemost 2010;103:989-93.
13. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995;80:58-68.
14. Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. Br J Haematol 2009;146:569-72.
15. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-61.
16. Abboud MR, Cure J, Granger S, et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004;103:2822-6.
17. Auer JW, Berent R, Weber T, Eber B. Iron metabolism and development of atherosclerosis. Circulation 2002;106:e7; author reply e.
18. Aessopos A, Tsironi M, Andreopoulos A, Farmakis D. Heart disease in thalassemia intermedia. Hemoglobin 2009;33(Suppl 1):S170-6.
19. Lai ME, Vacquer S, Carta MP, Spiga A, Cocco P, Angius F, Mandas A, Dessi S. Thalassemia intermedia is associated with a proatherogenic biochemical phenotype. Blood Cells Mol Dis 2011;146:294-9.
20. Hahalis G, Kalogeropoulos A, Terzis G, Tselepis AD, Kourakli A, Mylona P, Grapsas N, Alexopoulos D. Premature atherosclerosis in non-transfusion-dependent beta-thalassemia intermedia. Cardiology 2011;118:159-63.
21. Osborne AG, ed. Diagnostic Imaging: Brain. Philadelphia, PA: Elsevier, 2004.
22. Brandao RA, de Carvalho GT, Reis BL, Bahia E, de Souza AA. Intracranial aneurysms in sickle cell patients: report of 2 cases and review of the literature. Surg Neurol 2009;72:296-9; discussion 9.
23. Vicari P, Choairy AC, Siufi GC, Arantes AM, Fonseca JR, Figueiredo MS. Embolization of intracranial aneurysms and sickle cell disease. Am J Hematol 2004;76:83-4.
24. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5:501-12.
25. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002;99:3014-8.
26. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001;139:385-90.
27. Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E, Wright E, Zimmerman R, Armstrong FD. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001;139:391-7.
28. Armstrong FD, Thompson RJ Jr, Wang W, Zimmerman R, Pegelow CH, Miller S, Moser F, Bello J, Hurtig A, Vass K. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 1996;97:864-70.
29. Bernaudin F, Verlhac S, Freard F, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol 2000;15:333-43.
30. Kugler S, Anderson B, Cross D, et al. Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. Arch Neurol 1993;50:629-35.
31. Vichinsky EP, Neumayr LD, Gold JI, et al. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010;303:1823-31.
32. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-8.
33. Takahashi W, Fujii H, Ide M, Takagi S, Shinohara Y. Atherosclerotic changes in intracranial and extracranial large arteries in apparently healthy persons with asymptomatic lacunar infarction. J Stroke Cerebrovasc Dis 2005;14:17-22.
34. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999;282:36-9.
35. Weber F, Knopf H. Incidental findings in magnetic resonance imaging of the brains of healthy young men. J Neurol Sci 2006;240:81-4.
36. Baumgart D, Egelhof T. [Preventive whole-body screening encompassing modern imaging using magnetic resonance tomography]. Herz 2007;32:387-94.
37. Ishikawa Y, Hirayama T, Nakamura Y, Ikeda K. Incidental cerebral aneurysms in acute stroke patients: comparison of asymptomatic healthy controls. J Neurol Sci 2010;298:42-5.